Venus Remedies Ltd.

1,738.1-1.56%

2026-08-21

Market Cap₹ 2,357 Cr.
Current Price₹ 1,738
High / Low₹ 2,044 / 424
Stock P/E0.0
Book Value₹ 535
Price to Book1.60
Dividend Yield0.57 %
ROCE20.4 %
ROE15.5 %
Face Value₹ 10

Add ratio to table

ABOUT

KEY POINTS

PROS

  • Company is almost debt free
  • Latest quarter profit grew 118.4% YoY, showing strong momentum
  • Operating margins have improved to 18.7% from 13.3%
  • Strong cash generation - operating cash flow backs reported profits (CFO/PAT 1.48x)
  • Working capital cycle has improved - days down from 156 to 118
  • Company generates healthy free cash flow

CONS

  • Though reporting repeated profits, the company pays out little dividend (13.5%)

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

EDIT COLUMNS
S.No.NameCMP Rs.P/EMar Cap Rs.Cr.Div Yld %NP Qtr Rs.Cr.Qtr Profit Var %Sales Qtr Rs.Cr.Qtr Sales Var %ROCE %OPM %
1.SUNPHARMA1901.0037.71456113.580.842901.2326.5315299.8810.9819.1128.81
2.DIVISLAB8587.0077.93227957.870.35902.0065.503080.0027.8021.5140.75
3.TORNTPHARM4994.9087.11189989.940.76566.003.284921.0057.3219.2733.81
4.CIPLA1437.6534.46116141.010.90785.55-39.187119.284.1316.0016.73
5.ZYDUSLIFE1108.8024.51110603.220.09990.20-34.908017.0023.9721.3924.54
6.LUPIN2203.1018.22100733.420.821416.9816.018276.8934.2828.8629.59
7.DRREDDY1181.3530.6098604.430.68435.60-69.108099.80-5.2113.7510.63
8.MANKIND2385.0048.2298499.540.04574.0929.124030.5912.8913.2426.30
9.LAURUSLABS1823.0090.0998498.920.113620.702139.4220263.101191.0018.2031.50
10.AUROPHARMA1606.4024.9092428.710.251032.0325.229150.3517.4412.7620.54
11.BIOCON412.10135.5967159.700.12136.8053.364336.0010.893.2619.54
12.VENUSREM1763.6520.292357.470.5722.97139.27178.8635.6021.8819.12
Detailed Comparison with:

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Jun 2023
99
85
Operating Profit
OPM %
Other Income
2
Interest
0
Depreciation
7
8
Tax %
47.14%
Net Profit
4
3
Equity Capital
13
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
13
Reserves
0
Promoter Pledge %
0.00%
Sep 2023
170
157
Operating Profit
OPM %
Other Income
3
Interest
0
Depreciation
6
10
Tax %
44.67%
Net Profit
5
4
Equity Capital
13
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
13
Reserves
0
Promoter Pledge %
0.00%
Dec 2023
131
118
Operating Profit
OPM %
Other Income
2
Interest
0
Depreciation
6
9
Tax %
10.20%
Net Profit
8
6
Equity Capital
13
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
13
Reserves
0
Promoter Pledge %
0.00%
Mar 2024
175
154
Operating Profit
OPM %
Other Income
4
Interest
0
Depreciation
6
19
Tax %
35.75%
Net Profit
13
9
Equity Capital
13
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
13
Reserves
0
Promoter Pledge %
0.00%
Jun 2024
106
92
Operating Profit
OPM %
Other Income
2
Interest
0
Depreciation
6
10
Tax %
55.85%
Net Profit
4
3
Equity Capital
13
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
13
Reserves
0
Promoter Pledge %
0.00%
Sep 2024
170
157
Operating Profit
OPM %
Other Income
8
Interest
0
Depreciation
6
15
Tax %
37.47%
Net Profit
9
7
Equity Capital
13
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
13
Reserves
0
Promoter Pledge %
0.00%
Dec 2024
172
150
Operating Profit
OPM %
Other Income
2
Interest
0
Depreciation
5
29
Tax %
17.98%
Net Profit
24
18
Equity Capital
13
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
13
Reserves
0
Promoter Pledge %
0.00%
Mar 2025
197
171
Operating Profit
OPM %
Other Income
4
Interest
0
Depreciation
4
25
Tax %
40.43%
Net Profit
15
11
Equity Capital
13
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
13
Reserves
0
Promoter Pledge %
0.00%
Jun 2025
132
119
Operating Profit
OPM %
Other Income
8
Interest
0
Depreciation
6
15
Tax %
20.48%
Net Profit
12
9
Equity Capital
13
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
13
Reserves
0
Promoter Pledge %
0.00%
Sep 2025
193
163
Operating Profit
OPM %
Other Income
2
Interest
0
Depreciation
6
26
Tax %
24.84%
Net Profit
19
14
Equity Capital
13
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
13
Reserves
0
Promoter Pledge %
0.00%
Dec 2025
180
143
Operating Profit
OPM %
Other Income
2
Interest
0
Depreciation
6
33
Tax %
24.05%
Net Profit
25
19
Equity Capital
13
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
13
Reserves
0
Promoter Pledge %
0.00%
Mar 2026
259
200
Operating Profit
OPM %
Other Income
5
Interest
0
Depreciation
6
58
Tax %
24.51%
Net Profit
43
33
Equity Capital
13
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
13
Reserves
0
Promoter Pledge %
0.00%
Jun 2026
179
149
Operating Profit
OPM %
Other Income
3
Interest
0
Depreciation
7
33
Tax %
21.69%
Net Profit
26
2
Equity Capital
13
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
13
Reserves
0
Promoter Pledge %
0.00%

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2017
375
328
Operating Profit
50
OPM %
13
Other Income
3
Interest
36
Depreciation
39
-25
Tax %
18
Net Profit
-20
EPS
0
Dividend Payout %
0
Minority Interest
0
Share of Associates
0
Adjusted EPS
-16
Minority Interest
0
Share of Associates
0
Adjusted EPS
-16
Mar 2018
355
312
Operating Profit
45
OPM %
13
Other Income
1
Interest
35
Depreciation
33
-23
Tax %
-13
Net Profit
-27
EPS
0
Dividend Payout %
0
Minority Interest
0
Share of Associates
0
Adjusted EPS
-22
Minority Interest
0
Share of Associates
0
Adjusted EPS
-22
Mar 2019
302
268
Operating Profit
39
OPM %
13
Other Income
5
Interest
25
Depreciation
33
-28
Tax %
4
Net Profit
-27
EPS
0
Dividend Payout %
0
Minority Interest
0
Share of Associates
0
Adjusted EPS
-22
Minority Interest
0
Share of Associates
0
Adjusted EPS
-22
Mar 2020
320
277
Operating Profit
47
OPM %
15
Other Income
4
Interest
13
Depreciation
31
-6
Tax %
-31
Net Profit
-8
EPS
0
Dividend Payout %
0
Minority Interest
0
Share of Associates
0
Adjusted EPS
-7
Minority Interest
0
Share of Associates
0
Adjusted EPS
-7
Mar 2021
515
468
Operating Profit
65
OPM %
13
Other Income
18
Interest
13
Depreciation
34
41
Tax %
-32
Net Profit
54
EPS
44
Dividend Payout %
0
Minority Interest
0
Share of Associates
0
Adjusted EPS
44
Minority Interest
0
Share of Associates
0
Adjusted EPS
44
Mar 2022
577
508
Operating Profit
77
OPM %
13
Other Income
8
Interest
0
Depreciation
33
45
Tax %
-10
Net Profit
49
EPS
37
Dividend Payout %
0
Minority Interest
0
Share of Associates
0
Adjusted EPS
37
Minority Interest
0
Share of Associates
0
Adjusted EPS
37
Mar 2023
538
476
Operating Profit
72
OPM %
13
Other Income
10
Interest
0
Depreciation
31
40
Tax %
28
Net Profit
29
EPS
22
Dividend Payout %
0
Minority Interest
0
Share of Associates
0
Adjusted EPS
22
Minority Interest
0
Share of Associates
0
Adjusted EPS
22
Mar 2024
575
514
Operating Profit
72
OPM %
13
Other Income
11
Interest
0
Depreciation
26
47
Tax %
35
Net Profit
31
EPS
23
Dividend Payout %
0
Minority Interest
0
Share of Associates
0
Adjusted EPS
23
Minority Interest
0
Share of Associates
0
Adjusted EPS
23
Mar 2025
644
569
Operating Profit
91
OPM %
14
Other Income
16
Interest
0
Depreciation
22
79
Tax %
34
Net Profit
53
EPS
39
Dividend Payout %
0
Minority Interest
0
Share of Associates
0
Adjusted EPS
39
Minority Interest
0
Share of Associates
0
Adjusted EPS
39
Mar 2026
769
625
Operating Profit
155
OPM %
20
Other Income
11
Interest
0
Depreciation
25
131
Tax %
24
Net Profit
99
EPS
74
Dividend Payout %
13
Minority Interest
0
Share of Associates
0
Adjusted EPS
74
Minority Interest
0
Share of Associates
0
Adjusted EPS
74
TTM
810
654
Operating Profit
OPM %
Other Income
11
Interest
0
Depreciation
25
149
Tax %
24
Net Profit
113
EPS
Dividend Payout %
Minority Interest
0
Share of Associates
0
Adjusted EPS
Minority Interest
0
Share of Associates
0
Adjusted EPS

COMPOUNDED SALES GROWTH

10 Years:
7%
5 Years:
8%
3 Years:
13%

COMPOUNDED PROFIT GROWTH

10 Years:
55%
5 Years:
13%
3 Years:
51%

STOCK PRICE CAGR

10 Years:
35%
5 Years:
28%
3 Years:
96%
1 Year:
246%

RETURN ON EQUITY

10 Years:
4%
5 Years:
10%
3 Years:
10%
Last Year:
16%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Corporate actions

2026

Aug 7

₹ 1

Rs.10.0000 per share(100%)Final Dividend

Mar 2017
Equity Capital
12
382
116
Trade Payables
31
227
Total Liabilities
767
389
Capital Work in Progress
66
29
140
0
Cash & Bank
3
140
Total Assets
767
Total Debt
308
Net Working Capital
56
Contingent Liabilities
2
Book Value per Share
319.42
Face Value
10.00
Total Debt
308
Net Working Capital
56
Contingent Liabilities
2
Book Value per Share
319.42
Face Value
10.00
Mar 2018
Equity Capital
12
356
117
Trade Payables
27
236
Total Liabilities
748
370
Capital Work in Progress
65
0
136
0
Cash & Bank
4
174
Total Assets
748
Total Debt
302
Net Working Capital
26
Contingent Liabilities
2
Book Value per Share
298.16
Face Value
10.00
Total Debt
302
Net Working Capital
26
Contingent Liabilities
2
Book Value per Share
298.16
Face Value
10.00
Mar 2019
Equity Capital
12
329
109
Trade Payables
33
249
Total Liabilities
732
347
Capital Work in Progress
65
0
141
0
Cash & Bank
1
178
Total Assets
732
Total Debt
294
Net Working Capital
-1
Contingent Liabilities
3
Book Value per Share
276.25
Face Value
10.00
Total Debt
294
Net Working Capital
-1
Contingent Liabilities
3
Book Value per Share
276.25
Face Value
10.00
Mar 2020
Equity Capital
12
320
81
Trade Payables
34
197
Total Liabilities
644
271
Capital Work in Progress
25
0
136
0
Cash & Bank
1
210
Total Assets
644
Total Debt
216
Net Working Capital
68
Contingent Liabilities
0
Book Value per Share
269.21
Face Value
10.00
Total Debt
216
Net Working Capital
68
Contingent Liabilities
0
Book Value per Share
269.21
Face Value
10.00
Mar 2021
Equity Capital
12
374
0
Trade Payables
68
92
Total Liabilities
547
244
Capital Work in Progress
25
0
120
0
Cash & Bank
30
127
Total Assets
547
Total Debt
48
Net Working Capital
126
Contingent Liabilities
0
Book Value per Share
313.10
Face Value
10.00
Total Debt
48
Net Working Capital
126
Contingent Liabilities
0
Book Value per Share
313.10
Face Value
10.00
Mar 2022
Equity Capital
13
436
0
Trade Payables
50
79
Total Liabilities
578
225
Capital Work in Progress
25
0
126
0
Cash & Bank
50
152
Total Assets
578
Total Debt
39
Net Working Capital
182
Contingent Liabilities
11
Book Value per Share
336.21
Face Value
10.00
Total Debt
39
Net Working Capital
182
Contingent Liabilities
11
Book Value per Share
336.21
Face Value
10.00
Mar 2023
Equity Capital
13
465
0
Trade Payables
49
82
Total Liabilities
609
200
Capital Work in Progress
26
20
114
0
Cash & Bank
53
196
Total Assets
609
Total Debt
39
Net Working Capital
246
Contingent Liabilities
40
Book Value per Share
357.63
Face Value
10.00
Total Debt
39
Net Working Capital
246
Contingent Liabilities
40
Book Value per Share
357.63
Face Value
10.00
Mar 2024
Equity Capital
13
495
0
Trade Payables
52
81
Total Liabilities
641
203
Capital Work in Progress
21
19
118
90
Cash & Bank
68
123
Total Assets
641
Total Debt
39
Net Working Capital
288
Contingent Liabilities
30
Book Value per Share
380.48
Face Value
10.00
Total Debt
39
Net Working Capital
288
Contingent Liabilities
30
Book Value per Share
380.48
Face Value
10.00
Mar 2025
Equity Capital
13
576
0
Trade Payables
69
55
Total Liabilities
713
214
Capital Work in Progress
26
84
100
99
Cash & Bank
78
111
Total Assets
713
Total Debt
0
Net Working Capital
276
Contingent Liabilities
38
Book Value per Share
441.01
Face Value
10.00
Total Debt
0
Net Working Capital
276
Contingent Liabilities
38
Book Value per Share
441.01
Face Value
10.00
Mar 2026
Equity Capital
13
676
0
Trade Payables
111
76
Total Liabilities
876
215
Capital Work in Progress
51
238
129
116
Cash & Bank
28
99
Total Assets
876
Total Debt
0
Net Working Capital
248
Contingent Liabilities
20
Book Value per Share
515.92
Face Value
10.00
Total Debt
0
Net Working Capital
248
Contingent Liabilities
20
Book Value per Share
515.92
Face Value
10.00

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2017
62
Cash from Investing
-18
Cash from Financing
-44
0
Free Cash Flow
62
OCF / Net Profit
-3.05
Cumulative 5-Year FCF
0
OCF / Net Profit
-3.05
Cumulative 5-Year FCF
0
Mar 2018
52
Cash from Investing
-11
Cash from Financing
-40
0
Free Cash Flow
40
OCF / Net Profit
-1.94
Cumulative 5-Year FCF
0
OCF / Net Profit
-1.94
Cumulative 5-Year FCF
0
Mar 2019
44
Cash from Investing
-11
Cash from Financing
-35
-2
Free Cash Flow
39
OCF / Net Profit
-1.61
Cumulative 5-Year FCF
0
OCF / Net Profit
-1.61
Cumulative 5-Year FCF
0
Mar 2020
78
Cash from Investing
-5
Cash from Financing
-72
1
Free Cash Flow
78
OCF / Net Profit
-9.45
Cumulative 5-Year FCF
0
OCF / Net Profit
-9.45
Cumulative 5-Year FCF
0
Mar 2021
132
Cash from Investing
56
Cash from Financing
-162
26
Free Cash Flow
132
OCF / Net Profit
2.44
Cumulative 5-Year FCF
350
OCF / Net Profit
2.44
Cumulative 5-Year FCF
350
Mar 2022
41
Cash from Investing
-17
Cash from Financing
-9
15
Free Cash Flow
41
OCF / Net Profit
0.84
Cumulative 5-Year FCF
330
OCF / Net Profit
0.84
Cumulative 5-Year FCF
330
Mar 2023
28
Cash from Investing
-51
Cash from Financing
0
-23
Free Cash Flow
28
OCF / Net Profit
0.97
Cumulative 5-Year FCF
318
OCF / Net Profit
0.97
Cumulative 5-Year FCF
318
Mar 2024
35
Cash from Investing
-7
Cash from Financing
0
28
Free Cash Flow
27
OCF / Net Profit
1.16
Cumulative 5-Year FCF
306
OCF / Net Profit
1.16
Cumulative 5-Year FCF
306
Mar 2025
83
Cash from Investing
-76
Cash from Financing
0
7
Free Cash Flow
59
OCF / Net Profit
1.58
Cumulative 5-Year FCF
287
OCF / Net Profit
1.58
Cumulative 5-Year FCF
287
Mar 2026
151
Cash from Investing
-182
Cash from Financing
-1
-32
Free Cash Flow
120
OCF / Net Profit
1.52
Cumulative 5-Year FCF
275
OCF / Net Profit
1.52
Cumulative 5-Year FCF
275

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2017
EPS (₹)
-16.40
Book Value (₹)
319.42
Dividend per Share (₹)
0.00
Cash EPS (₹)
15.45
Operating Margin %
13.42%
Net Margin %
-5.39%
ROE %
-4.83%
ROCE %
1.50%
-2.53%
Debtor Days
47
Inventory Days
135
Payable Days
53
128
Debt to Equity (x)
0.78x
Interest Coverage (x)
0.31x
1.29x
Revenue Growth %
-6.77%
Operating Profit Growth %
-37.18%
Net Profit Growth %
-1781.70%
0.00%
P/E (x)
0.00x
P/B (x)
0.00x
Dividend Yield %
0.00%
0.00x
Mar 2018
EPS (₹)
-21.54
Book Value (₹)
298.16
Dividend per Share (₹)
0.00
Cash EPS (₹)
4.98
Operating Margin %
12.60%
Net Margin %
-7.49%
ROE %
-6.98%
ROCE %
1.75%
-3.51%
Debtor Days
44
Inventory Days
142
Payable Days
51
135
Debt to Equity (x)
0.82x
Interest Coverage (x)
0.34x
1.12x
Revenue Growth %
-5.43%
Operating Profit Growth %
-11.20%
Net Profit Growth %
-31.32%
0.00%
P/E (x)
0.00x
P/B (x)
0.00x
Dividend Yield %
0.00%
0.00x
Mar 2019
EPS (₹)
-21.97
Book Value (₹)
276.25
Dividend per Share (₹)
0.00
Cash EPS (₹)
4.73
Operating Margin %
12.85%
Net Margin %
-8.98%
ROE %
-7.65%
ROCE %
-0.48%
-3.66%
Debtor Days
46
Inventory Days
167
Payable Days
61
152
Debt to Equity (x)
0.86x
Interest Coverage (x)
-0.12x
1.00x
Revenue Growth %
-14.99%
Operating Profit Growth %
-13.30%
Net Profit Growth %
-1.99%
0.00%
P/E (x)
0.00x
P/B (x)
0.00x
Dividend Yield %
0.00%
0.00x
Mar 2020
EPS (₹)
-6.67
Book Value (₹)
269.21
Dividend per Share (₹)
0.00
Cash EPS (₹)
18.49
Operating Margin %
14.57%
Net Margin %
-2.57%
ROE %
-2.44%
ROCE %
1.15%
-1.20%
Debtor Days
35
Inventory Days
158
Payable Days
70
123
Debt to Equity (x)
0.65x
Interest Coverage (x)
0.52x
1.31x
Revenue Growth %
6.09%
Operating Profit Growth %
20.23%
Net Profit Growth %
69.65%
0.00%
P/E (x)
0.00x
P/B (x)
0.00x
Dividend Yield %
0.00%
0.00x
Mar 2021
EPS (₹)
43.97
Book Value (₹)
313.10
Dividend per Share (₹)
0.00
Cash EPS (₹)
71.75
Operating Margin %
12.56%
Net Margin %
10.55%
ROE %
15.10%
ROCE %
10.80%
9.11%
Debtor Days
16
Inventory Days
91
Payable Days
55
52
Debt to Equity (x)
0.12x
Interest Coverage (x)
4.23x
2.43x
Revenue Growth %
60.70%
Operating Profit Growth %
38.54%
Net Profit Growth %
759.69%
0.00%
P/E (x)
0.00x
P/B (x)
0.00x
Dividend Yield %
0.00%
0.00x
Mar 2022
EPS (₹)
36.65
Book Value (₹)
336.21
Dividend per Share (₹)
0.00
Cash EPS (₹)
61.02
Operating Margin %
13.39%
Net Margin %
8.49%
ROE %
11.72%
ROCE %
9.55%
8.71%
Debtor Days
15
Inventory Days
78
Payable Days
57
35
Debt to Equity (x)
0.09x
Interest Coverage (x)
0.00x
3.20x
Revenue Growth %
12.07%
Operating Profit Growth %
19.54%
Net Profit Growth %
-9.74%
0.00%
P/E (x)
0.00x
P/B (x)
0.00x
Dividend Yield %
0.00%
0.00x
Mar 2023
EPS (₹)
21.67
Book Value (₹)
357.63
Dividend per Share (₹)
0.00
Cash EPS (₹)
45.14
Operating Margin %
13.34%
Net Margin %
5.39%
ROE %
6.25%
ROCE %
8.03%
4.88%
Debtor Days
39
Inventory Days
81
Payable Days
53
67
Debt to Equity (x)
0.08x
Interest Coverage (x)
0.00x
4.38x
Revenue Growth %
-6.77%
Operating Profit Growth %
-7.19%
Net Profit Growth %
-40.87%
0.00%
P/E (x)
0.00x
P/B (x)
0.00x
Dividend Yield %
0.00%
0.00x
Mar 2024
EPS (₹)
22.82
Book Value (₹)
380.48
Dividend per Share (₹)
0.00
Cash EPS (₹)
41.94
Operating Margin %
10.59%
Net Margin %
5.30%
ROE %
6.18%
ROCE %
8.77%
4.88%
Debtor Days
55
Inventory Days
73
Payable Days
52
77
Debt to Equity (x)
0.08x
Interest Coverage (x)
0.00x
4.96x
Revenue Growth %
6.98%
Operating Profit Growth %
0.71%
Net Profit Growth %
5.30%
5.30%
P/E (x)
14.30x
P/B (x)
0.86x
Dividend Yield %
0.00%
5.64x
Mar 2025
EPS (₹)
39.32
Book Value (₹)
441.01
Dividend per Share (₹)
0.00
Cash EPS (₹)
55.49
Operating Margin %
11.64%
Net Margin %
8.16%
ROE %
9.57%
ROCE %
13.91%
7.76%
Debtor Days
53
Inventory Days
62
Payable Days
59
57
Debt to Equity (x)
0.00x
Interest Coverage (x)
0.00x
3.62x
Revenue Growth %
12.04%
Operating Profit Growth %
25.72%
Net Profit Growth %
72.34%
72.34%
P/E (x)
7.62x
P/B (x)
0.68x
Dividend Yield %
0.00%
3.55x
Mar 2026
EPS (₹)
74.29
Book Value (₹)
515.92
Dividend per Share (₹)
10.00
Cash EPS (₹)
92.77
Operating Margin %
18.72%
Net Margin %
12.92%
ROE %
15.53%
ROCE %
20.43%
12.50%
Debtor Days
51
Inventory Days
55
Payable Days
85
21
Debt to Equity (x)
0.00x
Interest Coverage (x)
0.00x
2.56x
Revenue Growth %
19.28%
Operating Profit Growth %
71.15%
Net Profit Growth %
88.93%
88.93%
P/E (x)
11.11x
P/B (x)
1.60x
Dividend Yield %
1.21%
6.92x

Shareholding Pattern

Numbers in percentages

TRADES
Jun 2024
41.76
1.06
0.00
Government
0.00
57.18
Sep 2024
41.76
1.18
0.00
Government
0.00
57.06
Dec 2024
41.76
1.11
0.00
Government
0.00
57.13
Mar 2025
41.76
1.34
0.00
Government
0.00
56.90
Jun 2025
41.76
2.25
0.11
Government
0.00
55.89
Sep 2025
41.76
1.86
0.75
Government
0.00
55.63
Dec 2025
41.76
2.25
1.03
Government
0.00
54.96
Mar 2026
41.76
2.80
1.20
Government
0.00
54.24
Jun 2026
41.76
2.92
0.89
Government
0.00
54.43

Documents

Announcements

  • Shareholders meeting

    2026-08-21 - Voting Results and Scrutinizer's report. Earlier submitted file was not machine readable.

  • Shareholders meeting

    2026-08-21 - Venus Remedies Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on August 20, 2026. Further, the company has informed the Exchange regarding voting results.

Annual Reports

Nothing filed yet.

Credit Ratings

Nothing filed yet.

Concalls

Nothing filed yet.